Skip to content

Clinical trials

Observational Hyperlipoproteinemia Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Observational Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20101
20111
20121
20133
20146
20153
20167
20179
20183
20195
20202
20216
20223
20232
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status19
Recruiting11
Active, not recruiting3
Not yet recruiting2
Terminated2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)3
Novartis Pharmaceuticals3
Hospices Civils de Lyon2
Isfahan University of Medical Sciences2
Laval University2
Organon and Co2
REGENXBIO Inc.2
University College, London2
University of Pennsylvania2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II64
Cardiovascular Diseases12
Hypercholesterolemia10
Atherosclerosis9
Homozygous Familial Hypercholesterolemia5
Genetic Diseases, Inborn4
Coronary Artery Disease3
Aortic Valve Stenosis2
Diabetes Mellitus, Type 12
Hypertension2

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.